is glp 1 banned by wada Are GLP-1s Performance-Enhancing Drugs? WADA just added tirzepatide (mounjaro)

Retatrutide belongs to a newer investigational category because it targets GLP-1, GIP, and glucagon receptors rather than only one or two pathways

Weve started to see this now over and over again, says Drucker

Reduced cravings could theoretically contribute to lower caloric intake and gradual weight loss, but this has not been measured in a controlled trial

What are the risks and benefits

Supporting the relevance of our model, a recent study using stem cellderived hypothalamic arcuate-like neurons with induced BBS mutations has similarly shown impairments in leptin and insulin signaling (29), underscoring the role of primary cilia in energy homeostasis

Annie Moore, an internal medicine physician at the CU Anschutz School of Medicine